Stocktoria
Inspire Medical Systems, Inc. INSP
Inspire Medical Systems, Inc. (INSP) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the safe zone. It does not currently pay a dividend. FY2025 revenue was $912.0M at a 15.9% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -1.76 — elevated (above the −1.78 line — aggressive-accounting signals worth a closer look) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 6/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.537 |
| Retained earnings / assets | -0.161 |
| EBIT / assets | 0.056 |
| Equity / liabilities | 6.192 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| INSP | Inspire Medical Systems, Inc. | 6/9 | 9.88 | 9.1 | +13.6% |
| OFIX | Orthofix Medical Inc. | 5/9 | 1.02 | — | +2.9% |
| TNDM | TANDEM DIABETES CARE INC | 3/9 | -3.04 | — | +7.9% |
| ATEC | Alphatec Holdings, Inc. | 6/9 | -4.63 | — | +25% |
| IRTC | iRhythm Holdings, Inc. | 5/9 | 0.78 | — | +26.2% |
| EMBC | Embecta Corp. | 6/9 | 1.99 | 2.2 | -3.8% |
| NVCR | NovoCure Ltd | 3/9 | -2.29 | — | +8.3% |
About Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
FAQ
Is INSP financially healthy?
Inspire Medical Systems, Inc.'s Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does INSP pay a dividend?
No, Inspire Medical Systems, Inc. does not currently pay a dividend.
How profitable is INSP?
In FY2025, Inspire Medical Systems, Inc. had a net margin of 15.9% and a return on equity of 18.6%.
What is INSP's P/E ratio?
Inspire Medical Systems, Inc.'s trailing price-to-earnings (P/E) ratio is about 9.1×, based on its latest annual earnings.
What is the analyst price target for INSP?
The average Wall-Street price target for Inspire Medical Systems, Inc. is $50.92, about 12.6% below the recent price, from 12 analysts (consensus: hold).
Is INSP a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Inspire Medical Systems, Inc.: a Piotroski F-score of 6/9, an Altman Z″ in the safe zone, a P/E of about 9.1×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.